Table 2.
Univariable and multivariable logistic regression of factors associated with symptom response (n = 50)
| Univariable | Multivariable | |||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age | ||||
| <60 | 1.00 | 1.00 | ||
| 60‐69 | 0.58 (0.04‐7.66) | 0.682 | 0.17 (0.002‐15.90) | 0.448 |
| 70‐79 | 0.55 (0.05‐6.27) | 0.630 | 0.43 (0.01‐22.83) | 0.680 |
| 80‐89 | 3.00 (0.15‐59.89) | 0.472 | 4.55 (0.06‐369.69) | 0.499 |
| >=90 | NA | NA | NA | NA |
| Gender | ||||
| Male | 1.00 | 1.00 | ||
| Female | 1.11 (0.27‐4.55) | 0.886 | 0.32 (0.03‐3.81) | 0.370 |
| ECOG performance status | ||||
| 1 | 1.00 | 1.00 | ||
| 2 | 0.40 (0.07‐2.32) | 0.307 | 0.52 (0.06‐4.91) | 0.571 |
| 3 | 0.11 (0.01‐1.21) | 0.071 | 0.03 (0.0003‐1.99) | 0.099 |
| 4 | NA | NA | NA | NA |
| T stage | ||||
| <T4 | 1.00 | 1.00 | ||
| T4 | 0.48 (0.12‐1.96) | 0.308 | 1.22 (0.10‐14.90) | 0.875 |
| Disease status | ||||
| Locally advanced (M0) | 1.00 | 1.00 | ||
| Metastatic (M1) | 0.66 (0.12‐3.60) | 0.630 | 1.28 (0.09‐17.55) | 0.851 |
| Nodal positivity | ||||
| No (N0) | 1.00 | 1.00 | ||
| Yes (N1) | 1.18 (0.20‐6.79) | 0.854 | 1.37 (0.11‐16.57) | 0.803 |
| Chemotherapy | ||||
| None | 1.00 | 1.00 | ||
| Before RT | 0.40 (0.06‐2.82) | 0.358 | 1.93 (0.08‐44.15) | 0.681 |
| After RT | NA | NA | NA | NA |
OR was not available for some groups as all patients in those groups either died or survived.
ECOG, Eastern Cooperative Oncology Group; OR, odds ratio; CI, confidence interval; RT, radiotherapy; NA, not applicable.